rs121918683
|
MYC;CASC11
|
Burkitt Lymphoma
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs121918685
|
MYC;CASC11
|
Burkitt Lymphoma
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs28933407
|
MYC;CASC11
|
Burkitt Lymphoma
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs4645959
|
MYC;CASC11
|
Malignant neoplasm of breast
|
|
0.010 |
GeneticVariation |
BEFREE |
A joint analysis of the Polish and the German study population revealed a 54% increased risk for breast cancer associated with the heterozygous Asn11Ser variant (OR = 1.54, 95% CI 1.05-2.26, p = 0.028).
|
15929079 |
2005 |
rs4645959
|
MYC;CASC11
|
Breast Carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
A joint analysis of the Polish and the German study population revealed a 54% increased risk for breast cancer associated with the heterozygous Asn11Ser variant (OR = 1.54, 95% CI 1.05-2.26, p = 0.028).
|
15929079 |
2005 |
rs747141352
|
MYC;CASC11
|
Childhood Burkitt Lymphoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Among the 78 BLs in this series, an additional five had RHOA mutations resulting in a total incidence of 7/82 (8.5%) with c.14G>A (p.R5Q) being present in three cases.
|
25044415 |
2014 |
rs747141352
|
MYC;CASC11
|
Burkitt Lymphoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Among the 78 BLs in this series, an additional five had RHOA mutations resulting in a total incidence of 7/82 (8.5%) with c.14G>A (p.R5Q) being present in three cases.
|
25044415 |
2014 |
rs747141352
|
MYC;CASC11
|
Adult Burkitt Lymphoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Among the 78 BLs in this series, an additional five had RHOA mutations resulting in a total incidence of 7/82 (8.5%) with c.14G>A (p.R5Q) being present in three cases.
|
25044415 |
2014 |
rs4645959
|
MYC;CASC11
|
Breast Cancer, Familial
|
|
0.010 |
GeneticVariation |
BEFREE |
Here, we analysed the influence of the rare c-MYC Asn11Ser polymorphism on familial breast cancer risk by performing a case-control study with a Polish (cases n = 349; controls n = 441) and a German (cases n = 356; controls n = 655) study population.
|
15929079 |
2005 |
rs1057519918
|
MYC;CASC11
|
Cutaneous Melanoma
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519918
|
MYC;CASC11
|
Lymphoma, Non-Hodgkin, Familial
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519918
|
MYC;CASC11
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519918
|
MYC;CASC11
|
NEUROBLASTOMA, SUSCEPTIBILITY TO
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519918
|
MYC;CASC11
|
Esophageal carcinoma
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs750664148
|
MYC;CASC11
|
Cutaneous Melanoma
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs750664148
|
MYC;CASC11
|
Adenocarcinoma of lung (disorder)
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs750664148
|
MYC;CASC11
|
NEUROBLASTOMA, SUSCEPTIBILITY TO
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs750664148
|
MYC;CASC11
|
Lymphoma, Non-Hodgkin, Familial
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs750664148
|
MYC;CASC11
|
Esophageal carcinoma
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs756091827
|
MYC;CASC11
|
NEUROBLASTOMA, SUSCEPTIBILITY TO
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs756091827
|
MYC;CASC11
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs756091827
|
MYC;CASC11
|
Esophageal carcinoma
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs756091827
|
MYC;CASC11
|
Cutaneous Melanoma
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs756091827
|
MYC;CASC11
|
Lymphoma, Non-Hodgkin, Familial
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs4645948
|
MYC;CASC11
|
Anemia
|
|
0.010 |
GeneticVariation |
BEFREE |
In addition, rs4645948 (C>T) was conferred with increased risk of anemia (CT <i>vs</i> CC, OR=2.152, P=0.001) and severe leukopenia (CT <i>vs</i> CC, OR=1.893, P=0.034) for NPC patients receiving chemoradiotherapy.
|
30662535 |
2019 |